People with type 2 diabetes sought for new FreeStyle Libre 3 study

Healthcare professionals are being urged to encourage people living with type 2 diabetes to take part in a study looking at how the FreeStyle Libre 3 can benefit those with the condition.

Researchers from across the UK are recruiting individuals with type 2 diabetes using once daily basal insulin to see if the FreeStyle Libre 3 continuous glucose monitoring (CGM) system can improve glucose levels in people with the condition.

They will determine whether CGM using FreeStyle Libre 3 will improve HbA1c compared to self-monitoring blood glucose over 16 or 32 weeks in adults with sub-optimally controlled type 2 diabetes on basal insulin therapy.

Funded by Abbott Diabetes Care, the year-long study is being conducted by a team of diabetes specialists within the NHS, with Dr Lala Leelarathna and Dr Emma Wilmot acting as the joint chief investigators.

Professor Pratik Choudhary, from the University of Leicester, is also one of the study investigators. He said: “We have seen the huge impact of continuous glucose monitoring in type 1 diabetes, that was made possible due to high quality research.

“We now need studies like this to demonstrate the benefit of continuous glucose monitoring sensors in those with insulin treated type 2 diabetes, so they too can benefit from wider access to this technology.”

He added: “We have a few more months of recruitment to go and a number of clinical sites available across the country.

“Participants can also take part in the study completely remotely. We are looking for people with type 2 diabetes who are using once daily basal insulin.”

Those taking part will be reimbursed for their time and any reasonable travel costs associated with attending study visits.

For more information, visit https://www.freedm2.co.uk